Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Real-Time Price · USD
13.90
-0.28 (-1.97%)
Jul 18, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Vision Care | 2.74B | Log In | Log In | Log In | Log In | Upgrade |
Vision Care Growth | 6.52% | Log In | Log In | Log In | Log In | Upgrade |
Surgical | 843.00M | Log In | Log In | Log In | Log In | Upgrade |
Surgical Growth | 10.12% | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals | 1.21B | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Growth | 28.34% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals | 969.00M | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals Growth | 36.58% | Log In | Log In | Log In | Log In | Upgrade |
Devices | 1.80B | Log In | Log In | Log In | Log In | Upgrade |
Devices Growth | 9.35% | Log In | Log In | Log In | Log In | Upgrade |
OTC | 1.72B | Log In | Log In | Log In | Log In | Upgrade |
OTC Growth | 5.14% | Log In | Log In | Log In | Log In | Upgrade |
Branded and Other Generics | 281.00M | Log In | Log In | Log In | Log In | Upgrade |
Branded and Other Generics Growth | 4.67% | Log In | Log In | Log In | Log In | Upgrade |
Other Product | 17.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Product Growth | -5.88% | Log In | Log In | Log In | Log In | Upgrade |
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2018 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2018 |
Vision Care Capital Expenditures | Log In | Log In | Log In | Log In | Upgrade |
Vision Care Capital Expenditures Growth | Log In | Log In | Log In | Log In | Upgrade |
Surgical Segment Expenditures | Log In | Log In | Log In | Log In | Upgrade |
Surgical Segment Expenditures Growth | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Capital Expenditures | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Capital Expenditures Growth | Log In | Log In | Log In | Log In | Upgrade |
Corporate Capital Expenditures | Log In | Log In | Log In | Log In | Upgrade |
Corporate Capital Expenditures Growth | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Vision Care Segment Profit | 808.00M | Log In | Log In | Log In | Log In | Upgrade |
Vision Care Segment Profit Growth | 13.04% | Log In | Log In | Log In | Log In | Upgrade |
Surgical Segment Profit | 44.00M | Log In | Log In | Log In | Log In | Upgrade |
Surgical Segment Profit Growth | -48.00% | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Segment Profit | 256.00M | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Segment Profit Growth | -13.71% | Log In | Log In | Log In | Log In | Upgrade |
Corporate Segment Profit | -614.00M | Log In | Log In | Log In | Log In | Upgrade |
Corporate Segment Profit Growth | 17.16% | Log In | Log In | Log In | Log In | Upgrade |
Amortization of Intangible Assets | -288.00M | Log In | Log In | Log In | Log In | Upgrade |
Amortization of Intangible Assets Growth | 9.34% | Log In | Log In | Log In | Log In | Upgrade |
Net Other Expense | -44.00M | Log In | Log In | Log In | Log In | Upgrade |
Net Other Expense Growth | -22.97% | Log In | Log In | Log In | Log In | Upgrade |
Other | 44.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -27.03% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
U.S. and Puerto Rico | 2.41B | Log In | Log In | Log In | Log In | Upgrade |
U.S. and Puerto Rico Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Total International | 2.38B | Log In | Log In | Log In | Log In | Upgrade |
Total International Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Vision Care Revenue Organic Change | - | Log In | Log In | Log In | Log In | Upgrade |
Vision Care Revenue Organic Change Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Revenue Organic Change | - | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Revenue Organic Change Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Surgical Revenue Organic Change | - | Log In | Log In | Log In | Log In | Upgrade |
Surgical Revenue Organic Change Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Total Revenue Organic Change | - | Log In | Log In | Log In | Log In | Upgrade |
Total Revenue Organic Change Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Vision Care Revenue Change in Constant Currency | 10.00 | Log In | Log In | Log In | Log In | Upgrade |
Vision Care Revenue Change in Constant Currency Growth | -21.43% | Log In | Log In | Log In | Log In | Upgrade |
Surgical Revenue Change in Constant Currency | 11.00 | Log In | Log In | Log In | Log In | Upgrade |
Surgical Revenue Change in Constant Currency Growth | 67.86% | Log In | Log In | Log In | Log In | Upgrade |
Total Revenue Change in Constant Currency | 17.00 | Log In | Log In | Log In | Log In | Upgrade |
Total Revenue Change in Constant Currency Growth | -6.78% | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Revenue Change in Constant Currency | 45.00 | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Revenue Change in Constant Currency Growth | -2.68% | Log In | Log In | Log In | Log In | Upgrade |